Saylors, R L <br/><br/>
Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: a Pediatric Oncology Group phase II study.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Aug 2001 
 - 3463-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2001.19.15.3463  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bone Neoplasms--drug therapy<br/>Child<br/>Child, Preschool<br/>Cyclophosphamide--administration & dosage<br/>Female<br/>Humans<br/>Infant<br/>Infusions, Intravenous<br/>Male<br/>Neoplasm Recurrence, Local--drug therapy<br/>Neoplasms--drug therapy<br/>Neuroblastoma--drug therapy<br/>Osteosarcoma--drug therapy<br/>Rhabdomyosarcoma--drug therapy<br/>Sarcoma, Ewing--drug therapy<br/>Topotecan--administration & dosage